Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Invested Capital (2019 - 2025)

Korro Bio's Invested Capital history spans 7 years, with the latest figure at $51.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital fell 67.93% year-over-year to $51.4 million, compared with a TTM value of $51.4 million through Dec 2025, down 67.93%, and an annual FY2025 reading of $51.4 million, down 67.93% over the prior year.
  • Invested Capital for Q4 2025 was $51.4 million at Korro Bio, down from $99.0 million in the prior quarter.
  • The five-year high for Invested Capital was $198.1 million in Q2 2024, with the low at -$153.3 million in Q3 2023.
  • Average Invested Capital over 5 years is $76.8 million, with a median of $115.6 million recorded in 2022.
  • Biggest YoY gain for Invested Capital was 290.84% in 2023; the steepest drop was 269.71% in 2023.
  • Tracing KRRO's Invested Capital over 5 years: stood at -$41.4 million in 2021, then crashed by 115.18% to -$89.0 million in 2022, then soared by 290.84% to $169.9 million in 2023, then dropped by 5.59% to $160.4 million in 2024, then tumbled by 67.93% to $51.4 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Invested Capital are $51.4 million (Q4 2025), $99.0 million (Q3 2025), and $115.1 million (Q2 2025).